UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Six Characters in Search of An Author: The History of the Nomenclature of Coagulation Factors

British journal of haematology, 2003-06, Vol.121 (5), p.703-712

Giangrande, Paul L. F.

2003

Volltextzugriff (PDF)

Pancreas allograft thrombosis

Transplantation, 2010-10, Vol.90 (7), p.705-707

2010

Volltextzugriff (PDF)

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

Blood, 2007-08, Vol.110 (3), p.815-825

2007

Volltextzugriff (PDF)

The history of blood transfusion

British journal of haematology, 2000-09, Vol.110 (4), p.758-767

Giangrande, Paul L. F.

2000

Volltextzugriff (PDF)

Air travel and thrombosis

British journal of haematology, 2002-06, Vol.117 (3), p.509-512

GIANGRANDE, Paul L. F

2002

Volltextzugriff (PDF)

Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation

Blood, 2000-10, Vol.96 (7), p.2496-2500

2000

Volltextzugriff (PDF)

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C

The Lancet (British edition), 1997-11, Vol.350 (9089), p.1425-1431

1997

Volltextzugriff (PDF)

Mortality before and after HIV infection in the complete UK population of haemophiliacs

Nature (London), 1995-09, Vol.377 (6544), p.79-82

1995

Volltextzugriff (PDF)

HEPATITIS IN HAEMOPHILIA

British journal of haematology, 1998-10, Vol.103 (1), p.1-9

Giangrande, Paul L. F.

1998

Volltextzugriff (PDF)

World Federation of Haemophilia Programs in Developing Countries

Seminars in thrombosis and hemostasis, 2005-11, Vol.31 (5), p.555-560

2005

Volltextzugriff (PDF)

Blood products for hemophilia: past, present and future

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2004-01, Vol.18 (4), p.225-234

Giangrande, Paul L F

2004

Volltextzugriff (PDF)

The impact of HIV on mortality rates in the complete UK haemophilia population

AIDS (London), 2004-02, Vol.18 (3), p.525-533

2004

Volltextzugriff (PDF)

World federation of haemophilia programs in developing countries: Hemophilia and von Willebrand disease in developing countries

Seminars in thrombosis and hemostasis, 2005, Vol.31 (5), p.555-560

2005

Volltextzugriff (PDF)

Increased bleeding associated with protease inhibitor therapy in HIV‐positive patients with bleeding disorders

British journal of haematology, 1999-12, Vol.107 (3), p.556-559

1999

Volltextzugriff (PDF)

Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation

Blood, 2000-10, Vol.96 (7), p.2496-2500

2000

Volltextzugriff (PDF)

Treatment of Bleeding in FVIII Inhibitor Patients

Current and Future Issues in Hemophilia Care, 2011, p.102-106

2011

Volltextzugriff (PDF)

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Commentary

Blood, 2007, Vol.110 (3)

2007

Volltextzugriff (PDF)

Thrombosis and air travel

Journal of travel medicine, 2000-05, Vol.7 (3), p.149-154

GIANGRANDE, P. L. E

2000

Volltextzugriff (PDF)

The molecular basis of hemophilia

Molecular Hematology, 2019, p.221-234

2019

Volltextzugriff (PDF)

The airline passenger: current medical issues

Travel medicine and infectious disease, 2003-05, Vol.1 (2), p.94-102

2003

Volltextzugriff (PDF)

Products Used to Treat Hemophilia: Plasma‐derived Coagulation Factor Concentrates

Textbook of Hemophilia, 2014, p.174-179

2014

Volltextzugriff (PDF)

Plasma‐Derived Coagulation Factor Concentrates

Textbook of Hemophilia, 2010, p.153-158

2010

Volltextzugriff (PDF)

Immunological effects of intermediate purity clotting factor concentrates: failure to affect lymphocyte activation in vivo

British journal of haematology, 1993-02, Vol.83 (2), p.296-305

1993

Volltextzugriff (PDF)

Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven®) in children vs. adults with haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-07, Vol.10 (4), p.352-359

2004

Volltextzugriff (PDF)

Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven®] in elective orthopaedic surgery in haemophilic patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-03, Vol.15 (2), p.501-508

2009

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(32)
Buchkapitel
(4)

Sprache

Englisch
(36)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Humans
(25)
Hematology
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(16)
Male
(10)
Haemophilia
(8)
Adolescent
(7)
Adult
(7)
Child
(7)
Hemophilia
(7)
Middle Aged
(7)
Aids/hiv
(5)
Child, Preschool
(5)
Hematologic And Hematopoietic Diseases
(5)
Hemophilia A - Complications
(5)
Hemophilia A - Therapy
(5)
Human Immunodeficiency Virus
(5)
Platelet Diseases And Coagulopathies
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Six Characters in Search of An Author: The History of the Nomenclature of Coagulation Factors

Pancreas allograft thrombosis

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

The history of blood transfusion

Air travel and thrombosis

Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C

Mortality before and after HIV infection in the complete UK population of haemophiliacs

HEPATITIS IN HAEMOPHILIA

World Federation of Haemophilia Programs in Developing Countries

Blood products for hemophilia: past, present and future

The impact of HIV on mortality rates in the complete UK haemophilia population

World federation of haemophilia programs in developing countries: Hemophilia and von Willebrand disease in developing countries

Increased bleeding associated with protease inhibitor therapy in HIV‐positive patients with bleeding disorders

Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation

Treatment of Bleeding in FVIII Inhibitor Patients

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Commentary

Thrombosis and air travel

The molecular basis of hemophilia

The airline passenger: current medical issues

Products Used to Treat Hemophilia: Plasma‐derived Coagulation Factor Concentrates

Plasma‐Derived Coagulation Factor Concentrates

Immunological effects of intermediate purity clotting factor concentrates: failure to affect lymphocyte activation in vivo

Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven®) in children vs. adults with haemophilia A

Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven®] in elective orthopaedic surgery in haemophilic patients with inhibitors

Suchergebnisse filtern